Sleepwave Gummies for Sleep

Biophoriaa Sleepwave Gummies combine 5 mg melatonin with 250 mg ashwagandha extract in strawberry-flavoured gummies aimed at improving sleep quality and reducing stress. The formula is straightforward—melatonin for sleep onset, ashwagandha for stress management—but lacks the supporting ingredients (L-theanine, magnesium, chamomile) found in more comprehensive sleep formulas at similar price points.

At ₹26.50 per serving, this product sits 23% above the Sleep & Recovery category average of ₹21.47, making it a premium-priced option for what is essentially a two-ingredient blend. The gummy format offers convenience and palatability, but the value proposition is weak unless you specifically prefer gummies over capsules and want this exact melatonin-ashwagandha combination.

The formula centres on two evidence-backed sleep ingredients. Melatonin is the go-to supplement for regulating circadian rhythm and reducing sleep latency, while ashwagandha (an adaptogen) addresses the stress and cortisol dysregulation that often interfere with sleep quality. The combination makes logical sense—melatonin tackles the immediate sleep-onset problem, ashwagandha works on the underlying stress that prevents deep sleep.

However, at 5.0/10, the formula score reflects its simplicity. There's no mention of ashwagandha standardisation (KSM-66, Sensoril, or withanolide content), which matters significantly for efficacy. More comprehensive sleep formulas typically include magnesium (for muscle relaxation and GABA support), L-theanine (for calming without sedation), or botanical extracts like chamomile or valerian. For a product priced above category average, the two-ingredient approach feels bare-bones.

Melatonin (5 mg): This dose is on the higher end of the clinical range. Research shows effective melatonin doses range from 0.3 mg to 5 mg, with 0.5–3 mg being optimal for most people. While 5 mg isn't dangerous, it's more than many users need and may cause next-day grogginess or tolerance issues with long-term use. This is clinically effective but potentially excessive for regular use.

Ashwagandha Extract (250 mg): Clinical studies typically use 300–600 mg daily (often split into two doses) for stress reduction and sleep improvement. At 250 mg per serving, this falls just below the lower clinical threshold. It's not underdosed dramatically, but it's borderline—ideally, you'd want 300 mg minimum. Without standardisation details, it's difficult to assess true withanolide content, which is the active compound responsible for ashwagandha's effects.

Overall dosing verdict: melatonin is clinically sufficient (arguably high), ashwagandha is slightly underdosed. Dosing score of 6.0/10 is fair.

At ₹795 for 30 servings (₹26.50 per serving), Sleepwave Gummies cost 23% more than the category average. For a two-ingredient formula—regardless of gummy format—this is steep. Comparable sleep supplements in the ₹15–22/serving range often include 4–6 ingredients with better-dosed actives.

The gummy format commands a premium due to manufacturing costs and palatability, but that doesn't fully justify the price gap given the basic formula. You're paying for convenience and taste rather than formula sophistication. The 4.3/10 value score reflects this mismatch between cost and ingredient depth.

Full marks here at 10.0/10. Both ingredients are clearly listed with exact milligram amounts—no proprietary blends, no "sleep complex" hiding doses. You know exactly what you're getting per gummy. The label mentions vegan and gluten-free certifications, which is helpful for those with dietary restrictions.

The only missing detail is ashwagandha standardisation (withanolide percentage or branded extract type). While not uncommon in the Indian market, disclosing this would elevate transparency further. Still, compared to many competitors using proprietary blends, Biophoriaa deserves credit for straightforward labelling.